New Zealand markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
237.96-3.43 (-1.42%)
At close: 04:00PM EST
238.09 +0.13 (+0.05%)
After hours: 06:39PM EST
Full screen
Trade prices are not sourced from all markets
Previous close241.39
Bid0.00 x 1300
Ask300.00 x 900
Day's range237.69 - 246.18
52-week range179.37 - 301.34
Avg. volume497,368
Market cap34.676B
Beta (5Y monthly)0.30
PE ratio (TTM)69.74
EPS (TTM)3.41
Earnings date27 Jan 2022
Forward dividend & yield1.68 (0.70%)
Ex-dividend date09 Nov 2021
1y target est276.50
  • Zacks

    ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    ResMed (RMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Motley Fool

    2 Healthcare Stocks That Could Help Set You Up for Life

    Repligen (NASDAQ: RGEN) and ResMed (NYSE: RMD) are two stocks which could fit that bill with their proven track records and growing opportunities. Repligen offers a unique way to invest in the healthcare space. Operating in both the downstream and upstream processes of drug development, Repligen sells products in the areas of filtration, chromatography, process analytics, and proteins.

  • Zacks

    Down 9.2% in 4 Weeks, Here's Why You Should You Buy the Dip in ResMed (RMD)

    The heavy selling pressure might have exhausted for ResMed (RMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.